. Thus, it has been reported that heparin activity is constant for 24 hours regardless of the diluting fluid or its pH over a wide range,'-4 or that heparin activity is reduced by 40-50% within 1 hour of dilution except in 0-9 00 sodium chloride,5 or that heparin activity is reduced by 50-60% after 4-6 hours in all diluents but then increases again with further storage.6
activity was stable when the drug was diluted in 0 9 % saline and stored in plastic, but a small loss of activity was observed in several studies after dilution in 5 % dextrose or storage in glass. A more extensive comparison confirmed a 3-5 % loss in heparin activity over 24 hours after dilution in 5°/' dextrose. Changing the pH to 3-5 or 10 0 had little effect on storage stability.
We conclude that heparin activity in vitro remains stable during short infusions but recommend dilution in 0 9 % saline and a plastic container when a heparin solution is infused over 24 hours.
Heparin is now commonly given by continuous intravenous infusion rather than by intermittent injection. For this mode of administration heparin is diluted in one of several intravenous infusion fluids and may then remain at room temperature in the infusion bag, bottle, or syringe for [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] hours. It is, therefore, important to know if its anticoagulant activity remains stable in vitro for this time. This question has been repeatedly investigated with varying results (Table) . Thus, it has been reported that heparin activity is constant for 24 hours regardless of the diluting fluid or its pH over a wide range,'-4 or that heparin activity is reduced by 40-50% within 1 hour of dilution except in 0-9 00 sodium chloride,5 or that heparin activity is reduced by 50-60% after 4-6 hours in all diluents but then increases again with further storage.6
Because of these contradictory and sometimes confusing reports about heparin stability in vitro we decided to re-investigate the question.
Further, because there is disagreement about the most appropriate test of heparin effect, we decided to measure heparin stability in vitro using four tests: the Received for publication 17 December 1979 activated partial thromboplastin time (APTT), the thrombin clotting time (TCT), factor Xa inhibitory activity (Xa time), and protamine sulphate neutralisation.
Methods

STUDY DESIGN
Sodium heparin was added to 500 ml 0 9 %0 saline or 5 0 dextrose, supplied commercially for intravenous use in plastic bags or glass bottles, to give a heparin activity of 10, 20, or 40 IU/ml, and to 50 ml 09 %0 saline or 5 % dextrose drawn into a plastic syringe to give a heparin activity of 400 or 1000 IU/ml. These conditions were chosen to mimic those obtaining during heparin infusion by intravenous drip or syringe pump. Heparin activity was assayed immediately and after 3, 6, and 24 hours of room temperature storage. In addition, heparin stability was measured during storage at varying pH. In some experiments the pH of 0 9y% saline and 5% dextrose was adjusted to 3-5 or 10-0 with 0-1 N HCl or 0 1 N NaOH before the addition of heparin.
HEPARIN ACTIVITY MEASUREMENTS
Heparin solutions were subsampled into pooled normal platelet poor plasma for the measurement of heparin activity after each storage interval. After a preliminary dilution, 10 or 20 Al of heparin solution were added to 10 ml plasma to yield a calculated final plasma activity of 0-2 IU/ml (assuming no change in activity with storage). at most a small loss of activity when heparin was diluted in 5% dextrose solution and kept in plastic containers. There was a statistically significant decrease in activity after 24 hours when the 10 IU/ml solution was tested by Xa time (Fig. 4) , the 40 IU/mI solution was tested by TCT (Fig. 5) , the 1000 IU/ml solution was tested by APTT (Fig. 5) , and the pH 10, 20 IU/ml solution was tested by APTT (Fig. 7) , but the apparent loss of activity was small: 9-11 % in all cases except for a 23 % loss of activity measured by Xa time.
Fig. 5 Heparin stability tested by APTT (clear bars) and TCT (shaded bars) after dilution to 20 IU/ml, 40 IUl ml, 400 IUlml, and 1000 IU/ml in 0.9% saline (above) or 5 % dextrose (below), and storage for 3, 6, and 24 hours in plastic bags (20 IU/ml and 40 IU/ml) or plastic syringes. Bars represent percent of initial activity ± SEM. *P < 0 05 **P < 0 01 (compared with initial activity). GLASS 
BOTTLES
In several experiments a statistically significant 10-14% loss of activity was recorded after 24 hours' storage in glass bottles. This was seen when activity was measured by APTT (10 IU/ml, 0 9y% saline) or TCT (40 IU/ml, 0-9 % saline; 20 IU/ml, 40 IU/ml, 5 % dextrose) (Fig. 6) . CONFIRMATORY 
STUDIES
In a second series of studies, 10 IU/ml heparin was stored for 24 hours in 20 500-ml plastic bags of 0 9% saline and 20 500-ml bags of 5% dextrose, and TCT (shaded bars) after dilution to J0 IU/ml, 20 IU/ml, and 40 IU/ml in commercial solutions of0 09% saline (above) or 5 % dextrose (below) sold for intravenous use in glass bottles. Bars represent percent of initial activity ± SEM after 3, 6, and 24 hours' storage. *P < 0 05 **P < 0-01 ***P < 0-001 (compared with initial activity).
heparin activity was measured by APTT and TCT at zero time and after 24 hours.
There was no change of heparin activity in 0 9%
saline (24-hour APTT = 99 9 + 0.6%; 24-hour TCT = 100-3 ± 0.6%Y. of initial activity), but a very small though statistically significant decrease of heparin activity in 5 % dextrose (24-hour APTT = 97.3 ± 0 9 %,24-hourTCT = 95 1 ± 13 %ofinitial activity; P < 0-01 for both observations).
Discussion
Our results suggest that there is no loss of heparin activity when heparin is diluted in 09 9% saline and stored in plastic for 24 hours at room temperature. Heparin also appears to be stable for 6 hours under other storage conditions, but a small loss was observed in some studies after 24 hours when the drug was diluted in 5 % dextrose or stored in glass;
this loss was no greater than 10-15Y% of initial activity. Further studies comparing heparin stability in 0-9 % saline and 5 % dextrose in plastic bags, using a larger sample of 20, confirmed that heparin is stable for 24 hours in 09 Y% saline, but showed a 3-5% loss of activity in 5% dextrose. Our results do not confirm the marked loss of heparin activity reported after dilution in 5% dextrose by Jacobs et al.,5 and after dilution in 5% dextrose or 0-9y% saline by Okuno and Nelson6 (Table) , and we are unable to explain these discrepancies. Our methods of measuring heparin activity differ from those used by Jacobs et al.5 but are similar to those of Okuno and Nelson. 6 We conclude that heparin activity in vitro remains stable during a short infusion, but, because of the small loss in activity after 24 hours when heparin is diluted in 5 % dextrose or stored in glass, we recommend dilution in 09 9% saline and storage in plastic containers when a heparin solution is to be infused over 24 hours.
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